title: Nosocomial and ventilator-associated pneumonia in a community hospital intensive care unit: a retrospective review and analysis.
abstract: BACKGROUND
  Nosocomial and ventilator-associated pneumonia (VAP) are causes of significant morbidity and mortality in hospitalized patients. We analyzed a) the incidence and the outcome of pneumonias caused by different pathogens in the intensive care unit (ICU) of a medium-sized twenty-four bed community hospital and b) the incidence of complications of such pneumonias requiring surgical intervention such as thoracotomy and decortication.
  
  
  RESULTS
  We retrospectively reviewed the charts of patients diagnosed with nosocomial and ventilator-associated pneumonia in our ICU. Their bronchoalveolar lavage (BAL) and sputum cultures, antibiograms, and other clinical characteristics, including complications and need for tracheostomy, thoracotomy and decortication were studied. In a span of one year (2011-12), 43 patients were diagnosed with nosocomial pneumonia in our ICU. The median simplified acute physiology score (SAPS II) was 39. One or more gram negative organisms as the causative agents were present in 85% of microbiologic samples. The three most prevalent gram negatives were Stenotrophomonas maltophilia (34%), Pseudomonas aeurginosa (40%), and Acinetobacter baumannii (32%). Twenty eight percent of bronchoalveolar samples contained Staphylococcus aureus. Eight three percent of patients required mechanical ventilation postoperatively and 37% underwent tracheostony. Thirty five percent underwent thoracotomy and decortication because of further complications such as empyema and non-resolving parapneumonic effusions. A. baumannii, Klebsiella pneumonia extended spectrum beta lactam (ESBL) and P. aeurginosa had the highest prevalence of multi drug resistance (MDR). Fifteen patients required surgical intervention. Mortality from pneumonia was 37% and from surgery was 2%.
  
  
  CONCLUSIONS
  Nosocomial pneumonias, in particular the ones that were caused by gram negative drug resistant organisms and their ensuing complications which required thoracotomy and decortication, were the cause of significant morbidity in our intensive care unit. Preventative and more intensive and novel infection control interventions in reducing the incidence of nosocomial pneumonias are strongly emphasized.
authors.affiliation: Georgia Health Sciences University, Doctors Hospital, Augusta, Georgia. docotrbehnia@gmail.com.
authors.forename: Mehrdad
authors.initials: M
authors.lastname: Behnia
authors.forename: Sharon C
authors.initials: SC
authors.lastname: Logan
authors.forename: Linda
authors.initials: L
authors.lastname: Fallen
authors.forename: Philip
authors.initials: P
authors.lastname: Catalano
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality / Q000601:surgery; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006090:Gram-Negative Bacteria / Q000187:drug effects / Q000254:growth & development; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality / Q000601:surgery; D006094:Gram-Positive Bacteria / Q000187:drug effects / Q000254:growth & development; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy / Q000382:microbiology* / Q000401:mortality / Q000601:surgery; D012189:Retrospective Studies; D016019:Survival Analysis; D013908:Thoracotomy; D014139:Tracheostomy
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Ann Thorac Surg. 2010 Jan;89(1):220-5
references.pmid: 20103240
references.citation: MedGenMed. 2007 Jul 05;9(3):4
references.pmid: 18092011
references.citation: J Hosp Infect. 2011 Sep;79(1):44-8
references.pmid: 21741117
references.citation: Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416
references.pmid: 15699079
references.citation: Crit Care Med. 2003 Oct;31(10):2478-82
references.pmid: 14530754
references.citation: J Hosp Med. 2011 Sep;6(7):405-10
references.pmid: 21916003
references.citation: Clin Infect Dis. 2008 Jun 1;46 Suppl 5:S378-85
references.pmid: 18462093
references.citation: Chest. 2006 Jul;130(1):251-60
references.pmid: 16840410
references.citation: Am J Infect Control. 2011 Sep;39(7):613-4
references.pmid: 21641086
references.citation: Eur J Cardiothorac Surg. 2007 Sep;32(3):422-30
references.pmid: 17646107
references.citation: Am J Med. 1993 Mar;94(3):281-8
references.pmid: 8452152
references.citation: Crit Care Med. 2012 Jan;40(1):330-2
references.pmid: 22179367
references.citation: Crit Care. 2006;10(5):R143
references.pmid: 17026755
references.citation: Interact Cardiovasc Thorac Surg. 2011 May;12(5):724-7
references.pmid: 21345817
references.citation: Chest. 2000 Oct;118(4):1158-71
references.pmid: 11035692
references.citation: BMC Pulm Med. 2010 Aug 26;10:45
references.pmid: 20796312
references.citation: Crit Care. 2011;15(1):R62
references.pmid: 21324159
references.citation: Eur J Pediatr. 2012 Feb;171(2):311-6
references.pmid: 21809011